A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644)

Clinical trial NCT05414786 · UNKNOWN

Trial details

NCT number: NCT05414786
Sponsor: International AIDS Vaccine Initiative
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2022-05-25
Primary completion: 2023-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.